162 results
8-K
EX-10.1
VTGN
VistaGen Therapeutics Inc
8 Sep 23
Vistagen to receive $1.5 million and Fuji to obtain time-limited exclusive negotiation period for the Japanese market
5:27pm
10-K
2023 FY
EX-10.162
VTGN
VistaGen Therapeutics Inc
Annual report
28 Jun 23
5:11pm
10-K
2023 FY
EX-10.159
VTGN
VistaGen Therapeutics Inc
Annual report
28 Jun 23
5:11pm
10-K
2023 FY
EX-10.161
VTGN
VistaGen Therapeutics Inc
Annual report
28 Jun 23
5:11pm
8-K
EX-10.1
1e0r0j6vkv
22 Jul 21
VistaGen Therapeutics Announces Appointment of Maggie FitzPatrick to its Board of Directors
4:06pm
8-K
EX-10.1
bi255 yn62b
8 Jul 21
VistaGen Therapeutics Announces Appointment of Mary L. Rotunno to its Board of Directors
4:15pm
8-K
EX-10.1
qrg1u2u6ckn9iq
27 Apr 21
VistaGen Therapeutics Announces Appointment of Joanne Curley, Ph.D. to its Board of Directors
4:05pm
8-K
EX-10.1
zlotobwqthy
26 Jun 20
Collaboration intended to support Phase 3 development and commercialization of PH94B in key Asian markets
5:27pm
8-K
EX-10
oj0x5w pwq
27 Apr 20
Entry into a Material Definitive Agreement
5:16pm
8-K
EX-10.2
2mseqcn5ksde hkkxl8
26 Mar 20
VistaGen Therapeutics Announces Common Stock Purchase Agreement for up to $10.25 Million
7:05am
8-K
EX-10.1
mzg123ra
26 Mar 20
VistaGen Therapeutics Announces Common Stock Purchase Agreement for up to $10.25 Million
7:05am
8-K
EX-10.1
r36tybzzpuptppf5
27 Jan 20
Entry into a Material Definitive Agreement
12:00am